Concepedia

Author

Christoph Hallmann

Boehringer Ingelheim (Germany)

Also Known As

C Hallmann, C. Hallmann, Christoph Hallmann

35

Publications

1K

Citations

10

H-Index

21

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Boehringer Ingelheim (United States)National Institute for Health ResearchUniversity of SouthamptonNIHR Southampton Respiratory Biomedical Research Unit
CH

About

Christoph Hallmann is an author at Boehringer Ingelheim (Germany) specializing in medicine, pulmonary disease, and acute lung injury.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

237

2

Pulmonary Disease

3

3

226

3

Pulmonary Medicine

2

2

32

4

Epidemiology

1

1

194

5

Nephrology

1

1

11

Christoph Hallmann

×

10

Publications

846

Citations

10

H-Index

YearCitations

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume

Martin Kolb, Luca Richeldi, Jürgen Behr,

Thorax

2016

227

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial

Peter M.A. Calverley, Antonio Anzueto, Kerstine Carter,

The Lancet Respiratory Medicine

2018

194

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life

Dave Singh, Gary T. Ferguson, J Bolitschek,

Respiratory Medicine

2015

171

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis

Harold R. Collard, Luca Richeldi, Dong Soon Kim,

European Respiratory Journal

2017

135

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

Christine Winchester, David Halpin, Ronald E. Dahl,

International Journal of COPD

2015

44

A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.

Ulrich Winkler, E. Daume, R Sudik,

PubMed

1999

22

Effect of baseline FVC on lung function decline with nintedanib in patients with IPF

Toby M. Maher, Kevin R. Flaherty, Paul W. Noble,

2015

17

S108 Effect of baseline FVC on decline in lung function with nintedanib in patients with IPF: results from the INPULSIS® trials

Martin Kolb, Takeshi Kimura, Susanne Stowasser,

Thorax

2015

15

Safety of tiotropium in renally impaired patients

Donald P. Tashkin, Norbert Metzdorf, Christoph Hallmann,

2014

11

A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 μg ethinylestradiol and either 2 mg chlormadinone acetate or 150 μg desogestrel

Ulrich Winkler, E. Daume, R Sudik,

The European Journal of Contraception & Reproductive Health Care

1999

10

Page 1